東方支付集團控股(08613.HK)完成認購事項
格隆匯2月22日丨東方支付集團控股(08613.HK)公佈,於本聯合公吿日期,認購協議所載完成的所有先決條件均已達成,而完成已於2022年2月22日落實。於完成後,東方支付已根據認購協議的條款及條件按認購價向認購人配發及發行全部認購股份。
認購股份相當於(i)東方支付於認購協議日期的全部已發行股本的20%;及(ii)緊隨完成後經配發及發行認購股份擴大後東方支付全部已發行股本約16.67%。
於本聯合公吿日期,緊隨東方支付向認購人配發及發行認購股份後,中國支付通於東方支付的股權將由32.50%攤薄至約27.08%,相當於減少東方支付全部已發行股本約5.42%的權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.